The Worldfolio: MEDIPOST: From Korea’s Stem-Cell Pioneer to Global Regenerative Medicine LeaderOctober 12, 2026
Research New Phase 3b data on Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) advance understanding of the interconnected immune and metabolic biology in adults with psoriasis and obesityBy Healthcare Propulsion StaffOctober 9, 20260 Exploratory data presented at Fall Clinical 2026 showed broader biomarker changes with Taltz and Zepbound vs. Taltz alone as early…
Research New Drug Combo With Zepbound Leads to Massive Weight LossBy Healthcare Propulsion StaffOctober 2, 20260 (Dreamstime)Zepbound is already one of the most powerful weight-loss drugs available. Now researchers have found that combining it with an…
